Prevalence of Sarcopenia-Promoting Medicines in Patients With Sarcopenia and Falls

Sarcopenia, characterised by the loss of muscle mass and function, is a common condition among the elderly and is often associated with increased risk of falls. Certain medications, such as glucocorticoids, statins, and some antipsychotics, may exacerbate sarcopenia, leading to a higher incidence of falls. This study aims to explore the prevalence of such medicines in patients diagnosed with sarcopenia who have experienced falls. Understanding the impact of these medications on sarcopenia and fall risk can inform clinical guidelines and improve patient outcomes.

Inclusion Criteria: * Aged ≥65 years * Attendance at the falls clinic for a new assessment * Diagnosed with sarcopenia (based on the European Working Group on Sarcopenia in Older People (EWGSOP2) criteria) * History of falls in the past 12 months Exclusion Criteria: * Cognitive impairment preventing consent * Acute medical instability * Enrolled in on other clinical trials.